These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37186510)

  • 1. Use of ultrafiltration/diafiltration for the processing of antisense oligonucleotides.
    Gronke RS; Ruanjaikaen K; Delavari A; Immel-Brown JP; Penrod JC; Lam Y; Antia FD
    Biotechnol Prog; 2023; 39(4):e3350. PubMed ID: 37186510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of solvents and small molecule impurities in antibody drug conjugates via ultrafiltration and diafiltration operation.
    Gates TJ; Lyu YF; Fang X; Liao X
    Biotechnol Prog; 2020 Jan; 36(1):e2923. PubMed ID: 31587515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of milk protein concentrates by ultrafiltration and continuous diafiltration: Effect of process design on overall efficiency.
    Gavazzi-April C; Benoit S; Doyen A; Britten M; Pouliot Y
    J Dairy Sci; 2018 Nov; 101(11):9670-9679. PubMed ID: 30172402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of ultrafiltration/diafiltration in removing organic and elemental process equipment related leachables from biological therapeutics.
    Sun B; Hadidi M; Santiago Nuñez J; Song B; Tumambac GE; Wong K; Kalinowski G; Hathcock JJ
    Biotechnol Prog; 2024; 40(1):e3400. PubMed ID: 37964726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration/diafiltration process of protein formulations.
    Yu Z; Moomaw JF; Thyagarajapuram NR; Geng SB; Bent CJ; Tang Y
    Biotechnol Prog; 2021 Mar; 37(2):e3106. PubMed ID: 33289341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies.
    Ladwig JE; Zhu X; Rolandi P; Hart R; Robinson J; Rydholm A
    Biotechnol Prog; 2020 Sep; 36(5):e2993. PubMed ID: 32185869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous ultrafiltration/diafiltration using a 3D-printed two membrane single pass module.
    Tan R; Franzreb M
    Biotechnol Bioeng; 2020 Mar; 117(3):654-661. PubMed ID: 31788780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody.
    Miao F; Velayudhan A; DiBella E; Shervin J; Felo M; Teeters M; Alred P
    Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Impurities from Sugar Excipient on Filtrate Flux during Ultrafiltration and Diafiltration Process.
    Lee J; Na J; Baek Y
    Membranes (Basel); 2021 Oct; 11(10):. PubMed ID: 34677543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the impact of sanitization methods for regenerated cellulose ultrafiltration/diafiltration membrane on membrane integrity and protein quality.
    Cong X; Chen W; Wang L; Wan Y
    Biotechnol Prog; 2023; 39(6):e3377. PubMed ID: 37470193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
    Abel J; Kosky A; Ball N; Bacon H; Kaushik R; Kleemann GR
    J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a scalable procedure by a discontinuous crossflow DF/UF to obtain a concentrate of chenopodin from a dead-end centrifugal UF at bench scale.
    Arazo M; Jaque N; Caro N; Abugoch L; Tapia C
    Food Chem; 2020 May; 313():126154. PubMed ID: 31931425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developability Assessments of Monoclonal Antibody Candidates to Minimize Aggregation During Large-Scale Ultrafiltration and Diafiltration (UF-DF) Processing.
    Whitaker N; Pace SE; Merritt K; Tadros M; Khossravi M; Deshmukh S; Cheng Y; Joshi SB; Volkin DB; Dhar P
    J Pharm Sci; 2022 Nov; 111(11):2998-3008. PubMed ID: 35940242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of annatto addition and bleaching treatments on ultrafiltration flux during production of 80% whey protein concentrate and 80% serum protein concentrate.
    Adams MC; Zulewska J; Barbano DM
    J Dairy Sci; 2013 Apr; 96(4):2035-2047. PubMed ID: 23415538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient separation of phycocyanin of Nostoc commune by multistep diafiltration using ultra-filtration membrane modules.
    Hidane T; Demura M; Morisada S; Ohto K; Kawakita H
    Bioprocess Biosyst Eng; 2023 Oct; 46(10):1447-1456. PubMed ID: 37532892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing scalable ultrafiltration/diafiltration process of monoclonal antibodies via mathematical modeling by coupling mass balances and Poisson-Boltzmann equation.
    Ambrožič R; Arzenšek D; Podgornik A
    Biotechnol Bioeng; 2021 Feb; 118(2):633-646. PubMed ID: 33049074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review.
    Holstein M; Hung J; Feroz H; Ranjan S; Du C; Ghose S; Li ZJ
    Biotechnol Bioeng; 2020 Nov; 117(11):3591-3606. PubMed ID: 32687221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-attribute PAT for UF/DF of Proteins-Monitoring Concentration, particle sizes, and Buffer Exchange.
    Rolinger L; Rüdt M; Diehm J; Chow-Hubbertz J; Heitmann M; Schleper S; Hubbuch J
    Anal Bioanal Chem; 2020 Apr; 412(9):2123-2136. PubMed ID: 32072210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streamlining process characterization efforts using the high throughput ambr® crossflow system for ultrafiltration and diafiltration processing of monoclonal antibodies.
    Fernandez-Cerezo L; Benner SW; Pollard JM
    Biotechnol Prog; 2021 May; 37(3):e3118. PubMed ID: 33369289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biorefinery of microalgal soluble proteins by sequential processing and membrane filtration.
    Safi C; Olivieri G; Campos RP; Engelen-Smit N; Mulder WJ; van den Broek LAM; Sijtsma L
    Bioresour Technol; 2017 Feb; 225():151-158. PubMed ID: 27888732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.